miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling.
Jie PengSusu ShiJuan YuJianli LiuHaixiang WeiHaixia SongShaoqiang WangZhejie LiShujin HeLei LiHongyan ZhangZhizhen YanRan ZhaoYukun LiuYanrong LiuJunjun LiRenya ZhangWei WangPublished in: Cancer cell international (2021)
Therefore, miR-378d expression is a good prognostic factor of patients with ESCC and regulates the malignant phenotype of tumor cells through AKT.